Cargando…
Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item‐score models
This study tested the hypothesis that analyzing longitudinal item scores of the Unified Parkinson's Disease Rating Scale could allow a smaller trial size and describe a drug's effect on symptom progression. Two historical studies of the dopaminergic drug ropinirole were analyzed: a cross‐o...
Autores principales: | Chen, Chao, Jönsson, Siv, Yang, Shuying, Plan, Elodie L., Karlsson, Mats O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099436/ https://www.ncbi.nlm.nih.gov/pubmed/33951753 http://dx.doi.org/10.1002/psp4.12601 |
Ejemplares similares
-
Item Response Model Adaptation for Analyzing Data from Different Versions of Parkinson’s Disease Rating Scales
por: Gottipati, Gopichand, et al.
Publicado: (2019) -
Improved Decision-Making Confidence Using Item-Based Pharmacometric Model: Illustration with a Phase II Placebo-Controlled Trial
por: Llanos-Paez, Carolina, et al.
Publicado: (2021) -
Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients
por: Llanos-Paez, Carolina, et al.
Publicado: (2022) -
Joint longitudinal model-based meta-analysis of FEV(1) and exacerbation rate in randomized COPD trials
por: Llanos-Paez, Carolina, et al.
Publicado: (2023) -
Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling
por: Ueckert, Sebastian, et al.
Publicado: (2014)